CRY2 and breast carcinoma: In previous studies, Cry2 showed a significant decrease in breast cancer [13], and higher Cry2 expression was associated with a longer metastasis-free survival time [29], suggesting that this circadian protein may be a tumor suppressor in breast cancer.